Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis

Background: Recent meta-analyses show that individuals with high risk variants in CHRNA5 on chromosome 15q25 are likely to develop lung cancer earlier than those with low-risk genotypes. The same high-risk genetic variants also predict nicotine dependence and delayed smoking cessation. It is unclear whether smoking cessation confers the same benefits in terms of lung cancer risk reduction for those who possess CHRNA5 risk variants versus those who do not.

Methods: Meta-analyses examined the association between smoking cessation and lung cancer risk in 15 studies of individuals with European ancestry who possessed varying rs16969968 genotypes (N=12,690 ever smokers, including 6988 cases of lung cancer and 5702 controls) in the International Lung Cancer Consortium.

Results: Smoking cessation (former vs. current smokers) was associated with a lower likelihood of lung cancer (OR=0.48, 95%CI=0.30-0.75, p=0.0015). Among lung cancer patients, smoking cessation was associated with a 7-year delay in median age of lung cancer diagnosis (HR=0.68, 95%CI=0.61-0.77, p=4.9∗10). The CHRNA5 rs16969968 risk genotype (AA) was associated with increased risk and earlier diagnosis for lung cancer, but the beneficial effects of smoking cessation were very similar in those with and without the risk genotype.

Conclusion: We demonstrate that quitting smoking is highly beneficial in reducing lung cancer risks for smokers regardless of their CHRNA5 rs16969968 genetic risk status. Smokers with high-risk CHRNA5 genotypes, on average, can largely eliminate their elevated genetic risk for lung cancer by quitting smoking- cutting their risk of lung cancer in half and delaying its onset by 7years for those who develop it. These results: 1) underscore the potential value of smoking cessation for all smokers, 2) suggest that CHRNA5 rs16969968 genotype affects lung cancer diagnosis through its effects on smoking, and 3) have potential value for framing preventive interventions for those who smoke.

Citing Articles

Identifying and assessing a prognostic model based on disulfidptosis-related genes: implications for immune microenvironment and tumor biology in lung adenocarcinoma.

Wang J, Liu K, Li J, Zhang H, Gong X, Song X Front Immunol. 2024; 15:1371831.

PMID: 38840910 PMC: 11150594. DOI: 10.3389/fimmu.2024.1371831.

Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.

Shin S, Kim T, Kim H, Cho J, Kang D, Park H Respir Res. 2024; 25(1):133.

PMID: 38500143 PMC: 10949658. DOI: 10.1186/s12931-024-02741-1.

Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.

Chen L, Baker T, Ramsey A, Amos C, Bierut L Addict Neurosci. 2023; 7.

PMID: 37602286 PMC: 10434839. DOI: 10.1016/j.addicn.2023.100083.

The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19.

Valencia-Perez Rea D, Falfan-Valencia R, Fricke-Galindo I, Buendia-Roldan I, Chavez-Galan L, Nava-Quiroz K Int J Mol Sci. 2023; 24(12).

PMID: 37372959 PMC: 10298344. DOI: 10.3390/ijms24129811.

Management of pulmonary nodules in women with pregnant intention: A review with perspective.

Zhang J, Tang K, Liu L, Guo C, Zhao K, Li S Ann Thorac Med. 2023; 18(2):61-69.

PMID: 37323371 PMC: 10263075. DOI: 10.4103/atm.atm_270_22.

References

. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010; 42(5):441-7. PMC: 2914600. DOI: 10.1038/ng.571. View

Chen L, Baker T, Piper M, Breslau N, Cannon D, Doheny K . Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry. 2012; 169(7):735-42. PMC: 3433845. DOI: 10.1176/appi.ajp.2012.11101545. View

. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002; 4(2):149-59. DOI: 10.1080/14622200210123581. View

Sarginson J, Killen J, Lazzeroni L, Fortmann S, Ryan H, Schatzberg A . Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet. 2011; 156B(3):275-84. DOI: 10.1002/ajmg.b.31155. View

Saccone N, Culverhouse R, Schwantes-An T, Cannon D, Chen X, Cichon S . Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010; 6(8). PMC: 2916847. DOI: 10.1371/journal.pgen.1001053. View

Young R, Hopkins R, Whittington C, Hay B, Epton M, Gamble G . Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One. 2011; 6(2):e16476. PMC: 3033394. DOI: 10.1371/journal.pone.0016476. View

Wang J, Spitz M, Amos C, Wu X, Wetter D, Cinciripini P . Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705. PMC: 3471886. DOI: 10.1371/journal.pone.0047705. View

Munafo M, Johnstone E, Walther D, Uhl G, Murphy M, Aveyard P . CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine Tob Res. 2011; 13(10):982-8. PMC: 3179672. DOI: 10.1093/ntr/ntr106. View

Kuryatov A, Berrettini W, Lindstrom J . Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function. Mol Pharmacol. 2010; 79(1):119-25. PMC: 3014277. DOI: 10.1124/mol.110.066357. View

10.

Amos C, Wu X, Broderick P, Gorlov I, Gu J, Eisen T . Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008; 40(5):616-22. PMC: 2713680. DOI: 10.1038/ng.109. View

11.

Tseng T, Park J, Zabaleta J, Moody-Thomas S, Sothern M, Chen T . Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. PLoS One. 2014; 9(9):e107268. PMC: 4169410. DOI: 10.1371/journal.pone.0107268. View

12.

Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

13.

Timofeeva M, Hung R, Rafnar T, Christiani D, Field J, Bickeboller H . Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012; 21(22):4980-95. PMC: 3607485. DOI: 10.1093/hmg/dds334. View

14.

Bergen A, Javitz H, Krasnow R, Nishita D, Michel M, Conti D . Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics. 2012; 23(2):94-103. PMC: 3563676. DOI: 10.1097/FPC.0b013e32835cdabd. View

15.

Hung R, Christiani D, Risch A, Popanda O, Haugen A, Zienolddiny S . International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008; 17(11):3081-9. PMC: 2756735. DOI: 10.1158/1055-9965.EPI-08-0411. View

16.

Brennan P, Hainaut P, Boffetta P . Genetics of lung-cancer susceptibility. Lancet Oncol. 2010; 12(4):399-408. DOI: 10.1016/S1470-2045(10)70126-1. View

17.

Thorgeirsson T, Gudbjartsson D, Surakka I, Vink J, Amin N, Geller F . Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet. 2010; 42(5):448-53. PMC: 3080600. DOI: 10.1038/ng.573. View

18.

Wang J, Spitz M, Amos C, Wilkinson A, Wu X, Shete S . Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010; 116(14):3458-62. PMC: 3073819. DOI: 10.1002/cncr.25085. View

19.

Spitz M, Amos C, Dong Q, Lin J, Wu X . The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008; 100(21):1552-6. PMC: 2720751. DOI: 10.1093/jnci/djn363. View

20.

Young R, Hopkins R, Hay B, Epton M, Black P, Gamble G . Lung cancer gene associated with COPD: triple whammy or possible confounding effect?. Eur Respir J. 2008; 32(5):1158-64. DOI: 10.1183/09031936.00093908. View